Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 1
- Adult 1
- Aged 1
- Aged, 80 and over 1
- Article 1
- Child 1
- Child, Preschool 1
- Female 1
- Follow-Up Studies 1
- global 1
- Humans 2
- Infant 1
- invasive pneumococcal disease 1
- Male 1
- Middle Aged 1
- pneumococcal conjugate vaccines 1
- Pneumococcal Infections 2
- pneumococcal meningitis 1
- Pneumococcal Vaccines 2
- Serogroup 2
- Streptococcus pneumoniae 1
- surveillance 1
- Vaccination 1
- Vaccine Efficacy 1
- Vaccines, Conjugate 1
- Young Adult 1
Personal Author
Corporate Author
Place as Subject
Resource Type General
Keywords
- 23-valent pneumococcal polysaccharide vaccine 1
- bacteria 1
- Denmark 1
- epidemiology 1
- invasive pneumococcal disease 1
- meningitis/encephalitis 1
- pneumococcal-conjugated vaccines 1
- pneumonia 1
- public health programs 1
- respiratory infections 1
- streptococci 1
- Streptococcus pneumoniae 1
- vaccine effectiveness 1
Select all docs (Max 200)
1 -
3 of 3 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (1)
- Adult (1)
- Aged (1)
- Aged, 80 and over (1)
- Article (1)
- Child (1)
- Child, Preschool (1)
- Female (1)
- Follow-Up Studies (1)
- global (1)
- Humans (2)
- Infant (1)
- invasive pneumococcal disease (1)
- Male (1)
- Middle Aged (1)
- pneumococcal conjugate vaccines (1)
- Pneumococcal Infections (2)
- pneumococcal meningitis (1)
- Pneumococcal Vaccines (2)
- Serogroup (2)
- Streptococcus pneumoniae (1)
- surveillance (1)
- Vaccination (1)
- Vaccine Efficacy (1)
- Vaccines, Conjugate (1)
- Young Adult (1)
- 23-valent pneumococcal polysaccharide vaccine (1)
- bacteria (1)
- Denmark (1)
- epidemiology (1)
- invasive pneumococcal disease (1)
- meningitis/encephalitis (1)
- pneumococcal-conjugated vaccines (1)
- pneumonia (1)
- public health programs (1)
- respiratory infections (1)
- streptococci (1)
- Streptococcus pneumoniae (1)
- vaccine effectiveness (1)
- :Hanquet, Germaine ;Krizova, Pavla1 2022 | Emerg Infect Dis. 2022; 28(1):127-138:We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13...
- :Deloria Knoll, Maria ;Bennett, Julia C.4 02 2021 | Microorganisms. 2021; 9(4):Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjuga...
- :Nielsen, Katrine Finderup ;Nielsen, Lise Birk6-2024 | Emerg Infect Dis. 2024; 30(6):1164-1172:As a follow-up to a previous study, we investigated vaccine effectiveness (VE) of 23-valent pneumococcal polysaccharide vaccine (PPSV23) against invas...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.